Agilent Technologies Inc.'s Workflow Chosen by Metabolomics Australia for Major Initiative
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today announced a major strategic sale to Metabolomics Australia (MA), which will provide metabolomics services to Australian researchers. Valued at approximately $2.5 million, the order includes multiple HPLC, LC/MS, GC, GC/MS and CE instruments, plus specific software to facilitate analysis of metabolomic data.